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databases MEDLINE, EMBASE and PubMed from January 2000 to February 10th, 
2015. To be eligible, studies had to focus on asthmatic patients, include pulmo-
nary or eosinophil measurements, and quality of life data. Results: The review 
allowed retrieving 5,776 studies and 42 fulfilled the eligibility criteria. Twenty-five 
articles presented a correlation coefficient between lung function and quality 
of life. All, except one, conclude to a positive correlation between lung function 
and quality of life with R-values ranging from 0.008 to 0.790. Of the 25 studies, 
36% obtained an R-value of 0.4 and over, indicating a weak to moderate correla-
tion. Sixteen of these results were statistically significant. One article evaluated 
the correlation between sputum eosinophil levels and AQLQ and concluded to a 
non-statistically significant correlation with an R-value of -0.15. Fourteen articles 
did not evaluate the direct correlation between the parameters of interest but pre-
sented raw data of these parameters. Of these, 12 studies presented data that indi-
cate a correlation between FEV1 and quality of life with an increase in quality of 
life score, when FEV1 increases. ConClusions: The correlation coefficients found 
in the systematic review indicate that when lung function improves, and possibly 
when sputum eosinophil decreases, the quality of life improves. Furthermore, 
non-correlation studies that look at the same parameters support this 
hypothesis.
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objeCtives: Idiopathic Pulmonary Fibrosis is a rare fatal respiratory disease char-
acterized by a decline in lung function leading to deliberating limitations on activity 
which may negatively impact health-related quality of life. There is limited research 
on the outcome measures of IPF. Systematically reviewed all the outcome measures 
used in the treatment of IPF and critically appraise the measures used to evaluate 
the treatment result of IPF with the aim of drawing conclusions regarding the suit-
ability of these measures. Methods: Conducted a systematic review from Medline, 
EMBASE, EBM reviews, NICE, HTA written in English between 2008 and September 
2014. Data was extracted from the citation applying efficacy, safety and health-
related quality of life outcomes in the selected studies. Results: Lung function test 
is the most commonly used outcome measures. Exercise capacity and health-related 
quality of life are the secondly common outcomes used. Then mortality or acute 
exacerbation are the third most commonly used outcome measures. Dysponea 
and health related quality of life measures have at least two scales of measures 
used at the same time. Each of the measurements are used either alone or in com-
bination. The scale of measurement of mortality, survival, acute exacerbation vary 
accordingly. Mortality and survival are the most important outcomes to evaluate 
the efficacy of the treatment. Some studies used both of the mortality and survival, 
some used either one. ConClusions: The appropriate outcome measures in IPF are 
lung function test as Forced Vital Capacity 10% relative change at one year, exercise 
capacity 6-MWT with saturation measures, St. George’s Respiratory Questionnaire 
along with SF-36. Overall survival combines with progression-free survival represent 
important treatment targets in IPF. All these measures are suitable and essential 
measures should be considered when investigating the new therapies. Assessing 
dysponea scale with UCSD and HRCT scanning are appropriate but not necessary 
outcome measures.
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objeCtives: This study aimed to assess the health related quality of life of TB 
patients in Quetta. Methods: A cross-sectional study was conducted to assess 
the health related quality of life by administering a pre-validated question-
naire based on European Quality of Life scale EQ-5D was used to measure health 
related quality of life. Convenient sampling was used for gathering data along 
with facilitator to help and guide respondents who faced difficulty in filling it. 
SPSS 17 was used for Descriptive analysis to demonstrate patients’ demograph-
ics. Inferential statistics (Mann-Whitney and Kruskal Wallis test, p< 0.05) were 
used to evaluate the significance of study. Results: The study population is 
dominated (55% )with females and mean age of respondents was 34.85 13 years. 
Majority (57%) of respondents were single and (86%) having urban residency. The 
mean EQ-5D descriptive score and EQ-VAS score were 0.53 0.22 and 64.84 15.7 
respectively. The EQ-5D and EQ-VAS scores were influenced by demographic char-
acteristics education level, occupation and income. ConClusions: This study 
revealed that health related quality of life in TB patients is Lower and EQ-5D (util-
ity) scores were lowers as compared to EQ-VAS (perceived) scores. Respondents 
education level, occupation and income have impact on health related quality 
of life.
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objeCtives: This study aimed to evaluate the level of knowledge and aware-
ness of asthma among private and government schoolsteachers in urban area 
of Quetta. Methods: A cross-sectional study was conducted to assess thelevel 
of knowledge and awareness of asthma among teachers of 12 different schools 
by administering a pre-validated questionnaire which was developed in English 
(0.49), lung function (0.44), and shortness of breath (0.43). These three features 
were chosen as the most important in more than 40% of their presentations. Being 
able to walk further and/or for longer was selected as the most important feature 
in 33.8% of presentations but the overall BWS weight (0.18) was low because the 
feature was selected as least important in 16.3% of presentations. Explanations 
given for the importance of benefit features often were interrelated, suggesting 
dependency between such outcomes. The least important features were needing 
a blood test before starting medication (–0.58) and mild skin reaction at injec-
tion site (–0.51). ConClusions: Positive clinical outcomes were prioritised over 
harms or administration features of a treatment in this sample. Patients may not 
differentiate between breathing symptoms and functional ability when evaluat-
ing treatments.
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objeCtives: Asthma is one of the most common and burdensome chronic res-
piratory diseases. This pilot study aimed to explore the priorities of patients with 
severe asthma in relation to treatment. Methods: Interviews were conducted 
with 20 patients with self-reported severe asthma. Patients completed a brief 
best-worst scaling (BWS) exercise comprising 12 questions in which 17 features 
(benefits, harms, or administration features of an asthma treatment) were pre-
sented in sets of 5. On each question, patients indicated the most important and 
the least important feature when choosing whether to take a treatment. Frequency 
counts of features being selected as the most or least important were used to 
generate BWS weights for each feature. Weights ranged from –1 to +1, with a 
positive weight reflecting greater importance. Results: The sample consisted 
of 6 males and 14 females, whose age range was 23 to 60 years (median: 38 years). 
BWS weights showed that the most important features were improved shortness 
of breath (0.33), improved lung function (0.33), and halving the number of moder-
ate asthma attacks (0.27). These features were chosen as the most important in 
more than 25% of their presentations. Intravenous administration every 4 weeks, 
halving the number of severe attacks, and self-injection every 2 to 4 weeks also 
were selected as most important in more than 25% of presentations but the over-
all BWS weights were relatively low (less than 0.20) because these features were 
selected as least important in more than 15% of presentations. The least impor-
tant features were mild skin reaction at injection site (–0.71) and needing a blood 
test before starting medication (–0.63). ConClusions: This sample of patients 
with asthma prioritised improved breathing, lung function, and reduced moder-
ate asthma attacks over potential harms or administration features. There was 
significant heterogeneity in preferences for individual features.
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objeCtives: To determine which patient-reported outcome (PRO) tools were used 
in studies on respiratory diseases published in 2014. Methods: An evidence sur-
veillance process was established based on a systematic search of PubMed, incor-
porating all studies published from 2010 and updated weekly, with a final search 
on 18 May 2015. Abstracts identified by the search that reported quality of life out-
comes in respiratory disorders were identified, based on ICD-10 classifications. 
Articles were included if they reported results or a study protocol from a primary 
research study or were a systematic review. PRO tools were identified from the 
abstract alone, where possible. Results: The search identified 1,980 articles pub-
lished in 2014, 1713 of which met the inclusion criteria. Of these, 171 (10%) were in 
respiratory disorders. Overall, 90 different PRO or clinician-reported instruments 
were used across 23 diseases, with 65 articles citing more than one tool. The most 
commonly researched diseases were COPD (60 articles), asthma (36), allergic rhinitis 
or rhinosinusitis (26), obstructive sleep apnoea (8) and bronchiectasis and cystic 
fibrosis (7 each). The St. George’s Respiratory Questionnaire (SGRQ) was the most 
commonly used PRO tool, in studies of COPD, asthma, bronchiectasis and emphy-
sema (36 articles), followed by the Asthma Quality of Life Questionnaire (13) and 
the Rhinoconjunctivitis Quality of Life tool (10). Utilities were measured in only 3 
studies, with SF-36 used twice and EQ-5D once. The PRO used was not specified in 
46 article abstracts: 20 of the 129 primary research articles, 3 of 7 study protocols 
and 23 of 35 systematic reviews. ConClusions: COPD and asthma were the most 
widely researched respiratory diseases in 2014, with the SGRQ the most widely used 
PRO. Utility values were rarely assessed directly, which, given the wide range of PRO 
tools used, provides a challenge to assessing and comparing cost-effectiveness of 
interventions across studies.
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objeCtives: Asthma is an inflammation of the respiratory functions character-
ized by symptoms such as dyspnea, wheezing, sputum production and cough that 
can significantly affect quality of life. The objective of this review was to explore 
the evidence on the possible correlation between lung function (FEV1 or FVC or 
PEF) or eosinophil levels and quality of life in asthmatic patients. Methods: A 
literature search was made using keywords such as “asthma”, “eosinophil”, “qual-
ity of life”, and “respiratory function”. The search was conducted in the electronic 
